InvestorsHub Logo
Followers 4
Posts 856
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Monday, 09/14/2020 8:49:46 AM

Monday, September 14, 2020 8:49:46 AM

Post# of 1707
Marshaling resources to fight COVID-19:

https://www.sandia.gov/news/publications/labnews/articles/2020/08-28/COVID_research.html

Researchers are developing a panel of immunoassays to enable the detection of viral antigens and anti-SARS-CoV-2 antibodies produced by hosts in response to infection. These immunoassays will be implemented through Sandia’s portable SpinDx platform, which offers rapid detection capabilities without requiring sample preparation. The SpinDx immunoassays will be complemented by a method for directly detecting viral RNA by coupling the quenching of unincorporated amplification signal reporters technique with reverse-transcription loop-mediated isothermal amplification. The combination of SpinDx immunoassays with QUASR RT-LAMP will provide a powerful method for diagnosing COVID-19 at all stages of disease. Moreover, researchers will be able to positively identify SARS-CoV-2 while ruling out influenza or other coronaviruses.

Lifeloc should really make a push to partner up with Sandia for the manufacture/distribution/sales/marketing of this product. Lifeloc needs to get moving on something!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News